Results for dulaglutide and kidney in type 2 diabetes: Exploratory analysis of the randomized, placebo-controlled trial of REWIND – The Lancet

[ad_1]
Results for dulaglutide and kidney in type 2 diabetes: exploratory badysis of the randomized, placebo-controlled trial of REWIND, The Lancet

[ad_2]
Source link